Loading... Please wait...


Our Newsletter

LX7101 | LIMK2 inhibitor

  • LX7101.jpg
  • LX7101, 400x400px, png
Catalog #:

Product Description

LX7101 is a pyrrolopyrimidine-based, topically-delivered inhibitor of LIM domain kinase 2 (LIMK2), a kinase associated with the regulation of intraocular pressure. LX7101 acts by enhancing fluid outflow through the trabecular meshwork of the eye. Preclinical studies indicate that LX7101 significantly reduced intraocular pressure in both mouse and monkey models. [1] LX7101 recently completed a randomized, double-blind, placebo-controlled Phase 1/2a trial for patients with open angle glaucoma or ocular hypertension. [2]

Technical information:

Chemical Formula:   C23H30ClN7O3
CAS #:   1192189-69-7
Molecular Weight:   487.98
Purity:   >98%
Appearance:   White
Chemical Name:   3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate hydrochloride
Solubility:   Up to 20 mM in DMSO
Synonyms:   LX-7101, LX7101

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Lexicon Genetics webpage
2. www.clinicaltrials.gov webpage for LX7101 Phase 1/2a trials (completed 8/12)

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the LX7101 | LIMK2 inhibitor to your wish list.

You Recently Viewed...